No matter what your preference in the stock market, the nature of the game is always going to revolve around returns. Without returns, there’s no point putting your money in the market. And few investment sectors can offer the high reward potential found in the healthcare segment, particularly biotech stocks. These research-oriented pharmaceutical firms, despite their high overhead and long lead times, always have that ‘holy grail’ waiting: a new drug or medical treatment to get approval – and w